4//SEC Filing
CRG Partners III - Parallel Fund (A) L.P. 4
Accession 0001209191-23-050864
CIK 0001492674other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 4:30 PM ET
Size
24.2 KB
Accession
0001209191-23-050864
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-09-27$0.19/sh−1,489,512$285,390→ 1,780,317 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−2,858,980$450,289→ 0 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−571,796$90,058→ 0 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,937,852$305,212→ 0 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−478,396$91,661→ 571,796 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,621,313$310,644→ 1,937,852 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−2,391,981$458,304→ 2,858,980 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,780,317$280,400→ 0 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.)
Capital Royalty L.P.
10% Owner
Transactions
- Sale
Common Stock
2023-09-27$0.19/sh−1,621,313$310,644→ 1,937,852 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,489,512$285,390→ 1,780,317 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−2,858,980$450,289→ 0 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,937,852$305,212→ 0 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−2,391,981$458,304→ 2,858,980 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,780,317$280,400→ 0 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−571,796$90,058→ 0 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−478,396$91,661→ 571,796 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.)
CRG Partners III L.P.
10% Owner
Transactions
- Sale
Common Stock
2023-09-28$0.16/sh−1,937,852$305,212→ 0 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,780,317$280,400→ 0 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−571,796$90,058→ 0 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−2,391,981$458,304→ 2,858,980 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−478,396$91,661→ 571,796 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−2,858,980$450,289→ 0 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,489,512$285,390→ 1,780,317 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,621,313$310,644→ 1,937,852 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.)
Transactions
- Sale
Common Stock
2023-09-27$0.19/sh−2,391,981$458,304→ 2,858,980 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,621,313$310,644→ 1,937,852 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,780,317$280,400→ 0 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,489,512$285,390→ 1,780,317 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−478,396$91,661→ 571,796 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−2,858,980$450,289→ 0 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−571,796$90,058→ 0 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,937,852$305,212→ 0 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.)
Transactions
- Sale
Common Stock
2023-09-27$0.19/sh−1,621,313$310,644→ 1,937,852 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−2,858,980$450,289→ 0 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,780,317$280,400→ 0 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−1,489,512$285,390→ 1,780,317 total(indirect: By CRG Partners III ? Parallel Fund ?A? L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−478,396$91,661→ 571,796 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−571,796$90,058→ 0 total(indirect: By CRG Partners III (Cayman) Unlev AIV I L.P.) - Sale
Common Stock
2023-09-27$0.19/sh−2,391,981$458,304→ 2,858,980 total(indirect: By CRG Partners III L.P.) - Sale
Common Stock
2023-09-28$0.16/sh−1,937,852$305,212→ 0 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.17 to $0.2178, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
- [F2]CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.15 to $0.175, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001651357
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 4:30 PM ET
- Size
- 24.2 KB